Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 18/20 | 0.41 |
| ▸ | FABP7 | O15540 | 2/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3366299 | 0.88 | FABP5 (0.51) | FFAR2FABP7FABP5 | |
| SCHEMBL31159434 | 0.88 | FABP5 (0.51) | FFAR2FABP7FABP5 | |
| SCHEMBL799703 | 0.88 | FABP5 (0.51) | FFAR2FABP7FABP5 | |
| Fluoride SCHEMBL7821537 | 0.86 | FABP5 (0.50) | FFAR2FABP7FABP5 | |
| SCHEMBL31369524 | 0.84 | FFAR2 (0.56) | FFAR2FABP7FABP5 | |
| SCHEMBL31369486 | 0.83 | ACE (0.47) | FFAR2FABP7FABP5 | |
| SCHEMBL31369417 | 0.82 | FFAR2 (0.44) | FFAR2FABP7FABP5 | |
| SCHEMBL31370144 | 0.81 | FABP5 (0.49) | FFAR2FABP7FABP5 | |
| SCHEMBL8124433 | 0.80 | FABP5 (0.49) | FFAR2FABP7FABP5 | |
| SCHEMBL13259973 | 0.79 | FABP5 (0.46) | FFAR2FABP7FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | FFAR2 3057/4885FABP7 224/4885FABP5 229/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | FFAR2 3403/4885FABP7 508/4885FABP5 424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.